Viewing Study NCT04346693


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT04346693
Status: COMPLETED
Last Update Posted: 2021-10-13
First Post: 2020-04-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Sponsor: Burnasyan Federal Medical Biophysical Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-04-08
Start Date Type: ACTUAL
Primary Completion Date: 2020-11-01
Primary Completion Date Type: ACTUAL
Completion Date: 2020-11-20
Completion Date Type: ACTUAL
First Submit Date: 2020-04-08
First Submit QC Date: None
Study First Post Date: 2020-04-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-05
Last Update Post Date: 2021-10-13
Last Update Post Date Type: ACTUAL